01 1Curia Italy S.r.l.
02 1Professional Compounding Centers of America dba PCCA
03 1Qingdao Biopeptek Co., Ltd.
04 1TAPI Czech Industries s.r.o.
05 1Teva Czech Industries s.r.o
01 2BROMOCRIPTINE MESYLATE
02 1Bromocriptine Mesylate
03 2Bromocriptine Mesylate Micronize
01 1Israel
02 2U.S.A
03 1United Kingdom
04 1Blank
NDC Package Code : 73212-035
Start Marketing Date : 2023-01-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55486-1561
Start Marketing Date : 2012-06-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-2274
Start Marketing Date : 2013-06-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 47848-003
Start Marketing Date : 2017-12-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84644-003
Start Marketing Date : 2017-12-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
85
PharmaCompass offers a list of Bromocriptine Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bromocriptine Mesylate manufacturer or Bromocriptine Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bromocriptine Mesylate manufacturer or Bromocriptine Mesylate supplier.
PharmaCompass also assists you with knowing the Bromocriptine Mesylate API Price utilized in the formulation of products. Bromocriptine Mesylate API Price is not always fixed or binding as the Bromocriptine Mesylate Price is obtained through a variety of data sources. The Bromocriptine Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 2-Bromine-alpha-ergocryptine methanesulfonate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 2-Bromine-alpha-ergocryptine methanesulfonate, including repackagers and relabelers. The FDA regulates 2-Bromine-alpha-ergocryptine methanesulfonate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 2-Bromine-alpha-ergocryptine methanesulfonate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 2-Bromine-alpha-ergocryptine methanesulfonate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 2-Bromine-alpha-ergocryptine methanesulfonate supplier is an individual or a company that provides 2-Bromine-alpha-ergocryptine methanesulfonate active pharmaceutical ingredient (API) or 2-Bromine-alpha-ergocryptine methanesulfonate finished formulations upon request. The 2-Bromine-alpha-ergocryptine methanesulfonate suppliers may include 2-Bromine-alpha-ergocryptine methanesulfonate API manufacturers, exporters, distributors and traders.
click here to find a list of 2-Bromine-alpha-ergocryptine methanesulfonate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 2-Bromine-alpha-ergocryptine methanesulfonate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 2-Bromine-alpha-ergocryptine methanesulfonate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 2-Bromine-alpha-ergocryptine methanesulfonate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 2-Bromine-alpha-ergocryptine methanesulfonate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 2-Bromine-alpha-ergocryptine methanesulfonate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 2-Bromine-alpha-ergocryptine methanesulfonate suppliers with NDC on PharmaCompass.
We have 4 companies offering 2-Bromine-alpha-ergocryptine methanesulfonate
Get in contact with the supplier of your choice:
